21
Participants
Start Date
May 1, 2017
Primary Completion Date
September 1, 2021
Study Completion Date
June 8, 2022
Post-transplant Grazoprevir and Elbasvir
Treatment will be started in the post-transplant patients on day 0 with the combination pill zepatier, containing grazoprevir 100mg/elbasvir 50mg by mouth once daily. The medications will be continued for a total of 12 weeks (16 weeks if resistance mutations, RAVs, are detected)
University of Maryland Medical Center, Baltimore
University of Maryland, Baltimore
OTHER